DFROT contains Difluprednate, designed especially for relieving the patient from post operative discomforts like swelling, pain, redness, irritation or inflammation. It also has a side benefit of treating Endogenous Anterior Uveitis.
DFROT formulated with one of the best corticosteroid present with the following properties-:
- High potency of binding with the receptors resulting in lesser dosage.
- Long half life decreases the need of frequent doses.
- Tissue level metabolism results in lower systematic steroid exposure.
It binds with the corticosteroid receptors and alters the protein synthesis thus prevents the leukocyte infiltration at the site of inflammation, interferes in the function of the mediators responsible for the inflammatory response, suppresses the humoral immune responses and reduction in edema or scar tissue. The anti-inflammatory actions involve phospholipase A2 inhibitory proteins which control the biosynthesis of potent mediators of inflammation such as prostaglandins.